NEW YORK (GenomeWeb News) — Researchers at Harvard Medical School and at Brigham & Womens Hospital will use BioTrove’s tools to study how humans respond to chemical weapons, and differentiation among adult stem cells, BioTrove said yesterday.
 
With funding from the US Defense Advanced Research Projects Agency, researchers at Brigham & Womens Center for Molecular Orthopedics and at Harvard have jointly purchased and installed BioTrove’s OpenArray NT Cycler and OpenArray plates, said BioTrove spokeswoman Arielle Bernstein.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.